Navigation Links
Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer

BREA, Calif., Jan. 16, 2012 /PRNewswire/ -- New Century Health announced today that its board of directors has appointed Atul Dhir, M.D., Ph.D., chief executive officer.  Dr. Dhir will spearhead the national expansion of New Century Health's specialty care management services focused on oncology and cardiology.  Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care that invested in New Century Health last year, recruited Dr. Dhir to the position.


Dr. Dhir joins New Century Health from his position as CEO of BiPar Sciences, Inc., a Sanofi-aventis biotech subsidiary that develops new cancer drugs.  He previously served as a senior executive with US Oncology, the largest provider of cancer care in the United States.  During his 10 years with the company, Dr. Dhir led several businesses, including the company's Cancer Research Group, one of the nation's leading cancer drug development companies.  Dr. Dhir has also held senior positions in the health care division of Monsanto Company and at McKinsey & Company.

"Dr. Dhir possesses a rare combination of deep scientific expertise and years of operational experience. He has an impressive 20-year history of leading and growing highly specialized health care businesses focused on transforming care," said Steve Cosler, chairman of New Century Health and an operating partner with Water Street.  "Dr. Dhir clearly stood out as the leader best suited to building on New Century's strong foundation to expand its services to payers and providers across the country."

Dr. Dhir has advised numerous health care organizations and currently serves on the advisory boards of several health care companies.  He completed his doctorate of philosophy in molecular biology from the University of Oxford, where he studied as a Rhodes Scholar.  He received his medical degree from the All India Institute of Medical Sciences in New Delhi, India. 

"My career has been dedicated to leading innovative organizations that are committed to improving health care on a large scale.  New Century Health has a unique and collaborative approach to improving the quality of patient care, while reducing the administrative work and overall costs of medical care in cancer, cardiology and other specialties.  I am excited to lead and grow the company to deliver these urgently needed services to patients, payers and providers across the country," said Dr. Dhir.

Dr. Dhir assumes the CEO position immediately.


About New Century Health

New Century Health is a national specialty care management company that provides innovative technology and clinical solutions to enhance the quality of patient care, while reducing the administrative work and improving the cost efficiency associated with the delivery of care.  Its customers include both payers and doctors providing specialty care services to members of Medicare, Medicaid and commercial payers. New Century Health is a company of Water Street, a strategic private equity firm focused exclusively on health care. New Century Health is an official licensee of the NCCN Drugs & Biologics Compendium™. To learn more about New Century Health, visit



SOURCE New Century Health
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Former Speaker of the House Newt Gingrich Featured Wednesday
2. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
3. Former Cables to Go/Lastar Inc. Employee's Move to Form American Consumer Cables Pays Off
4. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
5. Former Telomolecular CEO Clarifies SEC Settlement
6. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
7. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
8. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
9. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
10. Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America
11. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
Post Your Comments:
(Date:10/13/2015)... SPRINGS, Florida , October 13, 2015 ... AVXLD), Juno Therapeutics, Inc. (NASDAQ: JUNO ), and ... ARRY ), Avanex Life Sciences Corp. (OTCQX: AVXLD), ... Pharmaceuticals, Inc. (NASDAQ: PGNX ) --> ... and the biotech industry can potentially lead to advancements ...
(Date:10/13/2015)... -- TapImmune, Inc. (TPIV), a clinical-stage ... and gene-based immunotherapeutics and vaccines for the treatment of ... company at the Dawson James Small Cap Growth ... Jupiter, Florida on October 15, 2015. ... immunotherapy company specializing in the development of innovative peptide ...
(Date:10/13/2015)... ... October 13, 2015 , ... Clinovo recently appointed Jeff Parr and ... fast growing clinical data solutions business. , Jeff Parr has spent the past decade ... including Avery Dennison, Thermo Fisher, and Ab Sciex to name a few. He ...
(Date:10/13/2015)... 13, 2015 the United States ... .  PRCC represents about 14% of all new cases of kidney ... Canada and Europe . ...   --> Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) ... and AstraZeneca AB (publ) ("AstraZeneca") have completed enrolment in a global ...
Breaking Biology Technology:
(Date:9/24/2015)... NEW YORK , Sept. 24, 2015  EyeLock ... will be showcasing its award winning and latest technology ... Anaheim, California . EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA.   EyeLock,s platform uses video technology to deliver a ...
(Date:9/10/2015)... This report provides detailed descriptions of the ... emerging sensor types that will dominate in the future. ... the wearable technology hype curve in the last five ... feature with all of them is the prominence of ... useful functions. Sensors collect data about the physical and ...
(Date:9/10/2015)... Report Details The global wearable ... previous expectations of revenues, consumer adoption and even technological ... which wearables begin to achieve that mass market acceptance ... reasons is the entrance of Apple to the SmartWatches ... but the overall size of the wearable technology market. ...
Breaking Biology News(10 mins):